SG11202109928WA - Pharmaceutical composition for treating aortic aneurysm - Google Patents

Pharmaceutical composition for treating aortic aneurysm

Info

Publication number
SG11202109928WA
SG11202109928WA SG11202109928WA SG11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
aortic aneurysm
treating aortic
treating
aneurysm
Prior art date
Application number
Other languages
English (en)
Inventor
Naoki Unno
Hiroki Tanaka
Tatsuro YATA
Takafumi KAYAMA
Keisuke Inoue
Kiyoshi Toya
Original Assignee
National Univ Corporation Hamamatsu Univ School Of Medicine
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Univ Corporation Hamamatsu Univ School Of Medicine, Kowa Co filed Critical National Univ Corporation Hamamatsu Univ School Of Medicine
Publication of SG11202109928WA publication Critical patent/SG11202109928WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202109928W 2019-03-13 2020-03-13 Pharmaceutical composition for treating aortic aneurysm SG11202109928WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019045333 2019-03-13
PCT/JP2020/011042 WO2020184703A1 (ja) 2019-03-13 2020-03-13 大動脈瘤の治療用医薬組成物

Publications (1)

Publication Number Publication Date
SG11202109928WA true SG11202109928WA (en) 2021-10-28

Family

ID=72427139

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109928W SG11202109928WA (en) 2019-03-13 2020-03-13 Pharmaceutical composition for treating aortic aneurysm

Country Status (11)

Country Link
US (1) US20220184058A1 (ja)
EP (1) EP3939656A4 (ja)
JP (1) JPWO2020184703A1 (ja)
KR (1) KR20210144657A (ja)
CN (1) CN113316469A (ja)
BR (1) BR112021018017A2 (ja)
CA (1) CA3133209A1 (ja)
MX (1) MX2021010987A (ja)
SG (1) SG11202109928WA (ja)
TW (1) TW202100155A (ja)
WO (1) WO2020184703A1 (ja)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS572240A (en) 1980-06-06 1982-01-07 Sankyo Co Ltd Ml-236b derivative
PH23486A (en) 1982-11-22 1989-08-16 Sanzoz Inc Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
JP2569746B2 (ja) 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
TW338037B (en) 1995-10-05 1998-08-11 Otsuka Pharma Co Ltd Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition
ES2362534T3 (es) * 2005-06-08 2011-07-07 Kowa Company, Ltd. Nuevo agente reductor de los triglicéridos.
JP2007230884A (ja) * 2006-02-28 2007-09-13 Kowa Co 脊柱管狭窄症の予防及び／又は治療剤
US20140330022A1 (en) * 2012-01-05 2014-11-06 Kowa Company, Ltd. Collateral blood circulation development promoter
JP6367581B2 (ja) * 2014-03-18 2018-08-01 国立大学法人浜松医科大学 動脈瘤縮小剤

Also Published As

Publication number Publication date
CN113316469A (zh) 2021-08-27
JPWO2020184703A1 (ja) 2020-09-17
BR112021018017A2 (pt) 2021-11-23
EP3939656A4 (en) 2022-12-07
CA3133209A1 (en) 2020-09-17
WO2020184703A1 (ja) 2020-09-17
KR20210144657A (ko) 2021-11-30
EP3939656A1 (en) 2022-01-19
MX2021010987A (es) 2021-12-15
TW202100155A (zh) 2021-01-01
US20220184058A1 (en) 2022-06-16

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
IL290843A (en) A submucosal bioresorbable drug release platform
GB201911944D0 (en) Pharmaceutical compounds
GB201911517D0 (en) Pharmaceutical composition
GB201914910D0 (en) Pharmaceutical compounds
GB201907268D0 (en) Dental stent
IL291570A (en) Pharmaceutical preparations
GB201807053D0 (en) Pharmaceutical composition
SG11202103374TA (en) Pharmaceutical composition
SG11202109928WA (en) Pharmaceutical composition for treating aortic aneurysm
SG11202110315SA (en) Pharmaceutical composition
FI3908321T3 (fi) Farmaseuttinen koostumus
IL278964A (en) Pharmaceutical compositions for the treatment of sphingomyelinic acid deficiency
SG11202105231UA (en) Pharmaceutical composition for treating wounds
KR102324922B9 (ko) 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물
GB201915932D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
EP3461490C0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEMORRHOIDAL DISEASES
EP3682886A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AORTIC ANEURISM
IL289213A (en) A pharmaceutical preparation for tumor treatment
IL285728A (en) Pharmaceutical composition
EP3782603C0 (en) PHARMACEUTICAL COMPOSITION FOR TREATING GOUT
EP4066852A4 (en) PHARMACEUTICAL COMPOSITION
GB201912686D0 (en) Pharmaceutical composition
GB201908003D0 (en) Pharmaceutical composition